V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212162 | 20128646 | 1.59 | 68.6 | Curative (C) | 2017-12-26 | 2018-07-08 | null | null | N | NIVOLUMAB | 100304192 |
| 20212165 | 20128648 | 1.47 | 61 | Palliative (P) | 2019-02-19 | 2019-03-18 | null | 2 | Y | ECX | 100602016 |
| 20212167 | 20128650 | 1.69 | 61.4 | Adjuvant (A) | 2018-08-09 | 2018-08-12 | Panitumumab | N | null | PANITUMUMAB | 101006412 |
| 20212170 | 20128651 | 1.79 | 44.8 | Adjuvant (A) | 2021-05-08 | 2021-05-20 | null | 02 | N | ECX | 100411649 |
| 20212172 | 20128652 | 1.85 | 82.7 | Neo-adjuvant (N) | 2019-12-27 | 2020-01-15 | null | N | N | ECX | 101366351 |
| 20212174 | 20128653 | 1.7 | 97.4 | Neo-adjuvant (N) | 2017-12-14 | 2017-12-25 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101835548 |
| 20212176 | 20128654 | 1.52 | 70.9 | null | 2018-10-24 | 2018-11-15 | null | null | null | NIVOLUMAB | 100785556 |
| 20212177 | 20128655 | 1.76 | 93.8 | Neo-adjuvant (N) | 2019-04-07 | 2019-04-29 | Carboplatin + Etoposide IV 3 day | null | N | CARBOPLATIN + ETOPOSIDE | 101858302 |
| 20212179 | 20128656 | 1.69 | 93 | Palliative (P) | 2018-11-10 | 2018-11-12 | null | N | N | ECX | 100460579 |
| 20212185 | 20128657 | null | 85.05 | null | 2018-12-17 | 2018-12-26 | null | 2 | null | PANITUMUMAB | 100445216 |
| 20212186 | 20128658 | 1.69 | 70.3 | Adjuvant (A) | 2017-08-15 | 2017-08-24 | null | 02 | N | PANITUMUMAB | 101269498 |
| 20212189 | 20128659 | 1.73 | 95.5 | null | 2016-09-15 | 2016-11-07 | ECX | N | N | ECX | 100914396 |
| 20212190 | 20128660 | 1.78 | 94.7 | Palliative (P) | null | 2020-02-25 | null | N | N | ECX | 100065718 |
| 20212191 | 20128661 | 1.73 | null | Palliative (P) | null | 2016-05-15 | null | 02 | null | ECX | 100990268 |
| 20212193 | 20128662 | 1.72 | 79.6 | null | 2018-05-11 | 2018-05-22 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100754571 |
| 20212194 | 20128663 | 1.61 | 100 | Neo-adjuvant (N) | 2020-03-17 | 2020-04-09 | ECX | N | N | ECX | 101539571 |
| 20212201 | 20128664 | 1.78 | 72.3 | Palliative (P) | null | 2018-09-02 | Panitumumab | N | N | CARBOPLATIN + ETOPOSIDE | 100186421 |
| 20212204 | 20128666 | 1.78 | 98 | Curative (C) | 2017-06-29 | 2017-06-29 | null | 02 | N | NIVOLUMAB | 101119606 |
| 20212206 | 20128667 | 1.76 | 51.5 | Palliative (P) | 2018-10-20 | 2018-10-22 | Carboplatin + Etoposide iv&po | null | N | CARBOPLATIN + ETOPOSIDE | 100181657 |
| 20212207 | 20128668 | 1.75 | 92 | Adjuvant (A) | 2016-10-13 | 2016-11-01 | null | 02 | null | PANITUMUMAB | 100585277 |
| 20212210 | 20128670 | 1.7 | 48 | Curative (C) | 2020-03-29 | 2020-04-22 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101154535 |
| 20212212 | 20128671 | 1.67 | 78.85 | Palliative (P) | 2019-08-31 | 2019-09-14 | Panitumumab | 02 | N | PANITUMUMAB | 100643057 |
| 20212213 | 20128672 | 1.78 | 86.9 | Adjuvant (A) | 2021-05-08 | 2021-05-09 | NIVOLUMAB | null | N | NIVOLUMAB | 100376480 |
| 20212214 | 20128673 | 1.6 | 81.2 | Neo-adjuvant (N) | 2017-03-05 | 2017-03-07 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101175547 |
| 20212215 | 20128674 | 1.57 | 61.8 | null | 2017-07-23 | 2017-10-22 | Panitumumab | 02 | N | PANITUMUMAB | 100557966 |
| 20212216 | 20128675 | 1.62 | 43 | Neo-adjuvant (N) | 2020-02-14 | 2020-02-28 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101632812 |
| 20212218 | 20128676 | 1.58 | 58.6 | Adjuvant (A) | 2016-07-10 | 2016-08-01 | null | 02 | null | PANITUMUMAB | 100013972 |
| 20212222 | 20128677 | 1.69 | 43.5 | Neo-adjuvant (N) | 2016-08-01 | 2016-08-07 | Panitumumab | N | null | PANITUMUMAB | 100338107 |
| 20212223 | 20128678 | 1.76 | 71.9 | Palliative (P) | null | 2018-11-13 | null | N | null | ECX | 101586305 |
| 20212224 | 20128679 | 1.78 | 66.4 | null | null | 2018-03-31 | ECX | N | null | ECX | 100176857 |
| 20212228 | 20128681 | 1.63 | 84.2 | Palliative (P) | 2020-09-02 | 2020-09-20 | ECX | N | N | ECX | 101372162 |
| 20212229 | 20128682 | 1.56 | null | Adjuvant (A) | null | 2018-10-07 | null | null | N | CARBOPLATIN + ETOPOSIDE | 101306598 |
| 20212230 | 20128683 | 1.66 | 44.4 | Palliative (P) | 2017-02-16 | 2017-02-16 | null | N | null | ECX | 100313822 |
| 20212232 | 20128684 | null | 110.5 | Neo-adjuvant (N) | 2020-12-02 | 2020-12-03 | NIVOLUMAB | null | N | NIVOLUMAB | 100683263 |
| 20212234 | 20128685 | 1.77 | 68.9 | Adjuvant (A) | 2017-10-02 | 2017-10-13 | ECX | N | N | ECX | 101012465 |
| 20212237 | 20128686 | 1.84 | 52.7 | 03 | 2020-03-27 | 2020-03-27 | NIVOLUMAB | null | null | NIVOLUMAB | 101733458 |
| 20212238 | 20128687 | 1.67 | null | Curative (C) | 2017-03-16 | 2017-03-30 | CISPLATIN + FLUOROURACIL + RT | null | N | CISPLATIN + FLUOROURACIL | 100358011 |
| 20212243 | 20128690 | 1.58 | 86.1 | Curative (C) | 2017-06-16 | 2017-06-22 | NIVOLUMAB | 02 | Y | NIVOLUMAB | 101257014 |
| 20212244 | 20128691 | 1.7 | 74 | Adjuvant (A) | null | 2020-09-14 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100948701 |
| 20212246 | 20128692 | 1.67 | 70.3 | Adjuvant (A) | 2019-09-09 | 2019-09-10 | null | N | N | CISPLATIN + FLUOROURACIL | 101227608 |
| 20212248 | 20128693 | null | 75.6 | Adjuvant (A) | 2019-08-26 | 2019-09-16 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 101302826 |
| 20212251 | 20128694 | 1.7 | 85.5 | Neo-adjuvant (N) | null | 2018-10-07 | null | N | N | CISPLATIN + FLUOROURACIL | 101213979 |
| 20212256 | 20128695 | 1.52 | 77.5 | Palliative (P) | 2019-05-14 | 2019-05-27 | ECX | 02 | N | ECX | 100573885 |
| 20212258 | 20128697 | null | null | Palliative (P) | 2020-04-25 | 2020-04-26 | ECX | N | null | CARBOPLATIN + ETOPOSIDE | 101670376 |
| 20212260 | 20128698 | 1.76 | 74 | Adjuvant (A) | 2020-07-24 | 2021-12-25 | null | null | N | CARBOPLATIN + ETOPOSIDE | 100268445 |
| 20212262 | 20128699 | 1.7 | 49.8 | Neo-adjuvant (N) | 2017-09-14 | 2017-09-14 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 100124589 |
| 20212269 | 20128703 | 1.64 | 77.9 | null | 2018-12-03 | 2019-11-18 | NIVOLUMAB | N | null | NIVOLUMAB | 100808473 |
| 20212270 | 20128704 | 1.82 | 103 | null | 2016-05-28 | 2016-05-29 | null | 02 | Y | CISPLATIN + FLUOROURACIL | 101495003 |
| 20212271 | 20128705 | 1.76 | 80 | Neo-adjuvant (N) | 2017-05-07 | 2017-05-14 | NIVOLUMAB | null | N | NIVOLUMAB | 101801380 |
| 20212273 | 20128706 | 1.64 | 91 | Neo-adjuvant (N) | 2020-04-27 | 2020-04-28 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100213554 |